Y-shape pegylated somatropin: Clinical Trials

1 trial of Y-shape pegylated somatropin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow Y-shape pegylated somatropin: new trials by email Literature Review of Y-shape pegylated somatropin trials Research Report on Y-shape pegylated somatropin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Y-shape Pegylated Somatropin in Growth Hormone Deficiency Children
Y-shape pegylated somatropin, Norditropin®, Norditropin - Growth Hormone Deficiency
Phase 2 / Phase 3CompletedXiamen Amoytop Biotech Co., Ltd.4342018-12-262024-01-24

Conditions studied

Dwarfism, Pituitary (1)

Sponsors

Xiamen Amoytop Biotech Co., Ltd. (1)

Countries

China (1)

Top investigators

Xiaoping Luo, MD, Ph.D (1)

Results publications

PMID 36034448